AbbVie Inc (NYSE:ABBV)

63.12
Data as of Jan 29
 +1.27 / +2.05%
Today’s Change
45.50
Today|||52-Week Range
70.76
-3.55%
Year-to-Date
What to Expect When AbbVie (ABBV) Reports Fourth-Quarter Earnings Tomorrow
Jan 29 / TheStreet.com
Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog
Jan 27 / Zacks.com
Trading Radar for 1/30: MasterCard (MA), Altria (MO), Tyco (TYC), Lear (LEA), Xerox (...
Jan 29 / Investing Channel
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
Jan 27 / MotleyFool.com
Roche and Qualcomm in digital health alliance
Jan 29 / FT.com
Medtronic: the tax inversion that got away
Jan 27 / FT.com
Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog
Jan 29 / Zacks.com
These 3 Dividend Stocks Could Crush the Market in 2015
Jan 24 / MotleyFool.com
Getting Defensive Now
Jan 29 / TheStreet.com
Will Accuray (ARAY) Disappoint Earnings Estimates in Q2? - Analyst Blog
Jan 23 / Zacks.com
Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog
Jan 29 / Zacks.com
Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst Blog
Jan 23 / Zacks.com
Why AbbVie (ABBV) Might Surprise This Earnings Season - Tale of the Tape
Jan 29 / Zacks.com
Will Oncology Products Drive Bristol-Myers (BMY) Earnings? - Analyst Blog
Jan 23 / Zacks.com
Fast Money Halftime Report Final Trade From January 28
Jan 29 / Benzinga
Will Stryker (SYK) Disappoint this Earnings Season? - Analyst Blog
Jan 23 / Zacks.com
Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog
Jan 28 / Zacks.com
Will Pfizer (PFE) Beat Q4 Earnings Despite Generics? - Analyst Blog
Jan 23 / Zacks.com
Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog
Jan 28 / Zacks.com
Why Johnson & Johnson's Stock Could Crater in 2015
Jan 21 / MotleyFool.com
Apple Earnings Continue to Make Markets, Carl Icahn Very Happy
Jan 28 / TheStreet.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinica...
Jan 21 / Zacks.com
Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update?
Jan 28 / TheStreet.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog
Jan 20 / Zacks.com
Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog
Jan 28 / Zacks.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog
Jan 20 / Zacks.com
Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill
Jan 28 / TheStreet.com
Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog
Jan 20 / Zacks.com
Can St. Jude Medical (STJ) Keep Earnings Streak Alive? - Analyst Blog
Jan 27 / Zacks.com
Johnson & Johnson Overcomes Threats from Competitors, Delivers Solid Quarterly Result...
Jan 20 / MotleyFool.com
Will Cardinal Health (CAH) Surprise Earnings This Season? - Analyst Blog
Jan 27 / Zacks.com
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog
Jan 20 / Zacks.com
Will PerkinElmer's (PKI) Earnings Disappoint This Season? - Analyst Blog
Jan 27 / Zacks.com
Will Intuitive Surgical (ISRG) Disappoint Earnings in Q4? - Analyst Blog
Jan 20 / Zacks.com
Will AmerisourceBergen (ABC) Earnings Surprise in Q1? - Analyst Blog
Jan 27 / Zacks.com
Will Quality Systems (QSII) Surprise Earnings this Quarter? - Analyst Blog
Jan 20 / Zacks.com
Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog
Jan 27 / Zacks.com
Can AbbVie Inc. Overcome Humirabs Looming Patent Expiration?
Jan 20 / MotleyFool.com
Varian Medical (VAR): Will Earnings Disappoint in Q1? - Analyst Blog
Jan 27 / Zacks.com
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog
Jan 19 / Zacks.com
Will Baxter International (BAX) Disappoint Earnings in Q4? - Analyst Blog
Jan 27 / Zacks.com
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog
Jan 19 / Zacks.com
Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog
Jan 27 / Zacks.com
Celgene Up as Otezla Gains EU Approval for Two Indications - Analyst Blog
Jan 19 / Zacks.com
Will Biogen (BIIB) Surpass Q4 Earnings Expectations? - Analyst Blog
Jan 27 / Zacks.com
Is 1 Drug Really Outselling Legalized Marijuana?
Jan 19 / MotleyFool.com
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog
Jan 27 / Zacks.com
Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog
Jan 19 / Zacks.com
Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Jan 27 / Zacks.com
Will Logitech (LOGI) Keep the Earnings Streak Alive in Q3? - Analyst Blog
Jan 19 / Zacks.com

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.